Amiodarone-Induced Thyrotoxicosis Clinical Trial
Official title:
Pilot Study for Treatment of Amiodarone-Induced Thyroiditis With Radiofrequency Ablation
Investigators intend to study the changes in thyroid hormone storage and production in amiodarone-induced thyrotoxicosis patients after RFA therapy.
Investigators plan to identify patients with amiodarone-induced thyrotoxicosis (AIT) that failed to respond to medical therapy or have developed side effects from medical therapy or are considered high risk for such therapy. These patients will be offered the option to undergo radiofrequency ablation (RFA) of a portion of the thyroid gland in order to decrease thyroid hormone production and/or to inactive the existing thyroid hormone store before their leakage into the circulation. Investigators will follow these patients to assess their clinical response as well as their thyroid values. The safety of the procedure will also be assessed. ;